• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Halozyme Therapeutics Inc

+ Add to Watchlist


7.132 EUR 0.038 0.54%

As of 02:09:28 ET on 09/02/2014.

Snapshot for Halozyme Therapeutics Inc (HALOZ)

Open: 7.106 Day's Range: 7.106 - 7.132 Volume: 0
Previous Close: 7.094 52wk Range: 4.985 - 13.020 1-Yr Rtn: +1.11%

Stock Chart for HALOZ

No chart data available.
  • HALOZ:GR 7.109
  • 1D
  • 1M
  • 1Y
Interactive HALOZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HALOZ

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.6370
Est. PEG Ratio -
Market Cap (M EUR) 893.68
Shares Outstanding (M) 125.31
30 Day Average Volume 285
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HALOZ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HALOZ

Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.

Helen TorleyPresident/CEODavid A RamsayChief Financial Officer
H Michael Shepard "Mike"VP/Chief Scientific OfficerJean I LiuVP/Secretary/General Counsel
More Company Profile & Key Executives for HALOZ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil